期刊文献+

心脏手术后急性心功能衰竭患者采用静脉注射左西孟旦治疗的效果研究

Patients with Acute Cardiac Failure after Cardiac Surgery were Studied with Intravenous Injection of left Cimontan
下载PDF
导出
摘要 目的探讨心脏手术后急性心功能衰竭患者采用静脉注射左西孟旦治疗的效果研究。方法将2016年6月—2017年6月在该院治疗的78例心脏手术后急性心功能衰竭患者随机分为两组,对照组采用常规药物治疗,观察组在此基础上采用静脉注射左西孟旦治疗,比较两组患者的各生化指标情况、心超各指标情况。结果观察组术后7d的CK、CK-MB、LDH、c Tn T、NT-pro BNP水平较对照组明显改善,差异有统计学意义(P<0.05);观察组术后7?d的LVEDd、LVEF、短轴收缩率较对照组明显改善,组间统计学差异显著(P<0.05)。结论心脏手术后急性心功能衰竭患者采用静脉注射左西孟旦治疗有确切疗效,可有效改善左心功能,促进心功能各指标的改善,改善预后,具有积极的临床意义。 Objective To investigate the effect of intravenous injection of left cimontan for patients with acute cardiac failure after cardiac surgery.Methods From June 2016 to June 2017 in our hospital,78 patients with acute heart failure after cardiac surgery were randomly divided into two groups,control group using conventional drug treatment,observation group on the basis of intravenous levosimendan treatment,the situation of various biochemical indexes in two groups of patients and heart of each index were compared.Results The levels of CK,ck-mb,LDH,c Tn T and NT-pro BNP levels of 7 d after observation group were significantly improved compared with the control group,and the difference was statistically significant(P<0.05).After the observation group,the LVEDd,LVEF and short axis systolic rate of 7 d were significantly improved compared with the control group,and the statistical difference between groups was significant(P<0.05).Conclusion After heart surgery in patients with acute heart failure,treatment with intravenous levosimendan has exact curative effect,can effectively improve left heart function,improve the index of cardiac function,improve the prognosis,have positive clinical significance.
出处 《大医生》 2017年第5期22-23,共2页 Doctor
关键词 心脏手术后急性心功能衰竭 左西孟旦 治疗效果 heart failure after heart surgery left cimondan treatment effect
  • 相关文献

参考文献6

二级参考文献44

  • 1曾娅莉,黄文芳,卢贤瑜.细胞凋亡时线粒体钙离子信号调节因素研究进展[J].国际检验医学杂志,2006,27(6):543-545. 被引量:21
  • 2姚道阔,贾三庆.左西孟旦在心力衰竭中的应用[J].中国综合临床,2007,23(11):1054-1056. 被引量:6
  • 3Nijhawan N, Nicolosi AC, Montgomery MW, et al. Levosimendan en- hances cardia performance after cardiopulmonary bypass:a prospective, randomized placel~-contmlled trial. J Cardiovasc PharmacoI, 1999,34 : 219-228. 被引量:1
  • 4Nieminen MS, Akkila J, Hasenfuss G, et al. Hemodynarnic and neurehu- moral effects of continuous infusion of levesimendan in patients with con- gestive heart failure. J Am Coil Cardiol,2000,36:1903-1912. 被引量:1
  • 5Dec Gw. Acute decompensated heart failure shrinking role of inotropic therapy. J AM Coil Cardiol,2005,46:65-67. 被引量:1
  • 6Despas F,Trouillet C, Franchitto N, et al. Levosimedan improves hemody- namics functions without sympathetic activation in severe heart failure patients:direct evidence from sympathetic neural recording. Acute Card Care,2010,12:25-30. 被引量:1
  • 7Kivikko M, Lehtonen L, Colucci WS. Sustained hemodynamic effects of intravenous levosimendan. Circulation,2003,107 : 81-86. 被引量:1
  • 8Braun JP, Jasulaitis D, Moshirzadeh M, et al. Levosimendan may improve survival in patients requiring mechanical assist devices for post-cardioto- my heart failure. Crit Care ,2006 ,10 : R17. 被引量:1
  • 9v Maharaj R, Metaxa V. Levosimendan and mortality after coronary revascu- larisafion:a meta-analysis of randomised controlled trials. Crit Care, 2011,15 :R140. 被引量:1
  • 10Follath F, Cleland JG, Just H, et al. Efficacy and safety of intravenous levosimendan compared with dubutamine in severe lowoutput heart fail- ure( the LIDO study):a randomised donble-blind trial. Lancet,2002, 360 : 196-202. 被引量:1

共引文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部